Compare PepsiCo, Inc. (PEP) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PepsiCo, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? PepsiCo, Inc. trades at $127.86 (market cap $168.88B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: PepsiCo, Inc. is far larger — about 74.1× SELLAS Life Sciences Group Inc. Common Stock's market cap, and PepsiCo, Inc. pays a 4.78% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PEP | SLS | |
|---|---|---|
Market Cap | $168.88B | $2.28B |
Volume | 13,263,972 | 3,128,960 |
Sector | Consumer Staples | Health |
52-Week High | $170.44 | $15.46 |
52-Week Low | $123.64 | $1.39 |
Typical Hold Time | 107 Days | — |
Enterprise Value | $211.38B | $2.15B |
Dividend Yield | 4.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PepsiCo (PEP) trades at $128.88, up 2.52% today, with strong earnings momentum as it has beaten EPS estimates for four consecutive quarters. The stock shows bearish technical signals from moving averages but bullish oscillators, trading near support at $123. Fundamentally, PEP maintains solid profitability with 10.78% net margin and 51.59% ROE, though revenue growth remains modest at 2.2% in 2025. Recent news highlights price adjustments on snack products to address consumer pushback on high prices.
PEP offers value with a 16.22 P/E below industry averages and a 12.7% upside to the $145.25 consensus target, supported by 30% analyst buy ratings. However, risks include competitive pressure, margin compression from pricing actions, and technical weakness. The company's consistent dividend and earnings beats provide stability, but investors should monitor North American sales recovery and inflation impacts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
